The largest insider transaction on today's list is a Form 4 filing by Artal Group, which reported a purchase of roughly $40.4 million in Lexicon Pharmaceuticals $LXRX.
Artal Group now owns 83,835,950 LXRX shares, representing a roughly 47.5%...
One of the processes we absolutely love to follow is the Top/Down Analysis approach. In this process, we identify the larger trend, zoom in, and analyze the characteristics that stand out. We look at the asset classes, identify the strongest one, and...
Independent Director Robert Stallings reported an additional purchase of $1.2 million in Texas Capital Bancshares $TCB, as he continues to build his position.